Suppr超能文献

一项 EORTC 通讯问卷 EORTC QLQ-COMU26 的可靠性和有效性的国际现场研究。

An international field study for the reliability and validity of the EORTC communication questionnaire EORTC QLQ-COMU26.

机构信息

Oncology Departments, Hospital Universitario de Navarra, Navarra Institute for Health Research (IdiSNA), Irunlarrea 3, Pamplona, 31008, Spain.

University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.

出版信息

Health Qual Life Outcomes. 2024 Oct 10;22(1):87. doi: 10.1186/s12955-024-02298-z.

Abstract

BACKGROUND

The EORTC Quality of Life Group has developed a questionnaire to evaluate cancer patients' perception of their communication with healthcare professionals (HCPs): the EORTC QLQ-COMU26. In this study we test the validity and reliability of this novel measure in an international and culturally diverse sample of cancer patients.

METHODS

Cancer patients completed the following EORTC questionnaires at two time points (before and during treatment): the QLQ-COMU26 (including a debriefing questionnaire), the QLQ-C30, and specific IN-PATSAT32 scales. These data were used to assess: the cross-cultural applicability, acceptability, scale structure, reliability, convergent/divergent validity, known-groups validity, and responsiveness to change of the QLQ-COMU26.

RESULTS

Data were collected from 498 patients with various cancer diagnoses in 10 European countries, Japan, Jordan and India (overall 5 cultural regions). At most, only 3% of patients identified an item as confusing and 0.6% as upsetting, which indicates that the questionnaire was clear and did not trigger negative emotional responses. Confirmatory factor analysis and multi-trait scaling confirmed the hypothesised QLQ-COMU26 scale structure comprising six multi-item scales and four single items (RMSEA = 0.025). Reliability was good for all scales (internal consistency > 0.70; test-retest reliability > 0.85). Convergent validity was supported by correlations of ≥ 0.50 with related scales of the IN-PATSAT32 and correlations < 0.30 with unrelated QLQ-C30 scales. Known-groups validity was shown according to sex, education, levels of anxiety and depression, satisfaction with communication, disease stage and treatment intention, professional evaluated, and having a companion during the visit. The QLQ-COMU26 captured changes over time in groups that were defined based on changes in the item of satisfaction with communication.

CONCLUSION

The EORTC QLQ-COMU26 is a reliable and valid measure of patients' perceptions of their communication with HCPs. The EORTC QLQ-COMU26 can be used in daily clinical practice and research and in various cancer patient groups from different cultures. This questionnaire can help to improve communication between patients and healthcare professionals.

摘要

背景

欧洲癌症研究与治疗组织(EORTC)生活质量组开发了一种问卷,用于评估癌症患者对与医护人员(HCP)沟通的感知:EORTC QLQ-COMU26。在这项研究中,我们在国际和文化多样化的癌症患者样本中测试了这种新测量方法的有效性和可靠性。

方法

癌症患者在两个时间点(治疗前和治疗期间)完成了以下 EORTC 问卷:QLQ-COMU26(包括一份汇报问卷)、QLQ-C30 和特定的 IN-PATSAT32 量表。这些数据用于评估:QLQ-COMU26 的跨文化适用性、可接受性、量表结构、可靠性、聚合/发散有效性、已知组有效性和对变化的反应性。

结果

数据来自 10 个欧洲国家、日本、约旦和印度的 498 名患有各种癌症的患者(共 5 个文化区)。最多只有 3%的患者认为一个项目令人困惑,0.6%的患者感到不安,这表明问卷很清楚,不会引发负面情绪反应。验证性因子分析和多特质评分证实了假设的 QLQ-COMU26 量表结构,包括六个多项目量表和四个单项目量表(RMSEA=0.025)。所有量表的可靠性均良好(内部一致性>0.70;重测信度>0.85)。与 IN-PATSAT32 的相关量表的相关性≥0.50,与无关的 QLQ-C30 量表的相关性<0.30,支持了聚合有效性。根据性别、教育程度、焦虑和抑郁程度、对沟通的满意度、疾病阶段和治疗意图、专业评估以及就诊时是否有同伴,显示了已知组的有效性。根据对沟通满意度项目的变化,定义了几个组,QLQ-COMU26 能够捕获这些组随时间的变化。

结论

EORTC QLQ-COMU26 是一种可靠和有效的测量患者对与医护人员沟通感知的方法。EORTC QLQ-COMU26 可用于日常临床实践和研究以及来自不同文化的各种癌症患者群体。该问卷有助于改善患者与医护人员之间的沟通。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验